AN2 Therapeutics (ANTX) Preferred Dividend Payments (2021 - 2022)
AN2 Therapeutics (ANTX) reported Preferred Dividend Payments of $1.8 million for Q1 2022, up 139.16% year-over-year from $761000.0 in Q1 2021, and down 5.45% quarter-over-quarter from $1.9 million in Q4 2021.
AN2 Therapeutics (ANTX) Preferred Dividend Payments (2021 - 2022) Analysis & Trends
AN2 Therapeutics (ANTX) has 2 years of Preferred Dividend Payments data on file, last reported at $1.8 million in Q1 2022.
- Preferred Dividend Payments for Q1 2022 came in at $1.8 million, up 139.16% year-over-year; the trailing twelve-month figure through Dec 2022 was $1.8 million (down 72.06% YoY), and the FY2022 annual result was $1.8 million, down 72.06% from the prior year.
- Preferred Dividend Payments fell to $1.8 million in Q1 2022 per ANTX's latest filing, from $1.9 million in the prior quarter.
- Over five years, Preferred Dividend Payments peaked at $1.9 million in Q3 2021 and troughed at $761000.0 in Q1 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | - |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | AN2 Therapeutics | 161.95 Mn | 161.95 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | 1.82 Mn |
| Dec 31, 2021 | 1.93 Mn |
| Sep 30, 2021 | 1.93 Mn |
| Jun 30, 2021 | 1.90 Mn |
| Mar 31, 2021 | 761,000.00 |